{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:30:12Z","timestamp":1783110612110,"version":"3.54.6"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Acute rejection (AR) and recurrent hepatitis C virus (R-HCV) are significant complications in liver allograft recipients. Noninvasive diagnosis of intragraft pathologies may improve their management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We performed small RNA sequencing and microRNA (miRNA) microarray profiling of RNA from sera matched to liver allograft biopsies from patients with nonimmune, nonviral (NINV) native liver disease. Absolute levels of informative miRNAs in 91 sera matched to 91 liver allograft biopsies were quantified using customized real-time quantitative PCR (RT-qPCR) assays: 30 biopsy-matched sera from 26 unique NINV patients and 61 biopsy-matched sera from 41 unique R-HCV patients. The association between biopsy diagnosis and miRNA abundance was analyzed by logistic regression and calculating the area under the receiver operating characteristic curve.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Nine miRNAs\u2014miR-22, miR-34a, miR-122, miR-148a, miR-192, miR-193b, miR-194, miR-210, and miR-885-5p\u2014were identified by both sRNA-seq and TLDA to be associated with NINV-AR. Logistic regression analysis of absolute levels of miRNAs and goodness-of-fit of predictors identified a linear combination of miR-34a + miR-210 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001) as the best statistical model and miR-122 + miR-210 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001) as the best model that included miR-122. A different linear combination of miR-34a + miR-210 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001) was the best model for discriminating NINV-AR from R-HCV with intragraft inflammation, and miR-34a + miR-122 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001) was the best model for discriminating NINV-AR from R-HCV with intragraft fibrosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Circulating levels of miRNAs, quantified using customized RT-qPCR assays, may offer a rapid and noninvasive means of diagnosing AR in human liver allografts and for discriminating AR from intragraft inflammation or fibrosis due to R-HCV.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003815","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T19:08:16Z","timestamp":1620846496000},"page":"806-820","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot Study"],"prefix":"10.1097","volume":"106","author":[{"given":"Thangamani","family":"Muthukumar","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine and Department of Transplantation Medicine, New York Presbyterian-Weill Cornell Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemal M.","family":"Akat","sequence":"additional","affiliation":[{"name":"Laboratory of RNA Molecular Biology, The Rockefeller University, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine and Department of Transplantation Medicine, New York Presbyterian-Weill Cornell Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine and Department of Transplantation Medicine, New York Presbyterian-Weill Cornell Medicine, New York, NY."},{"name":"Department of Psychiatry and Behavioral Science, Stony Brook University, Stony Brook, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine and Department of Transplantation Medicine, New York Presbyterian-Weill Cornell Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejung","family":"Bang","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Public Health Sciences, University of California at Davis, Davis, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iddo Z.","family":"Ben-Dov","sequence":"additional","affiliation":[{"name":"Laboratory of RNA Molecular Biology, The Rockefeller University, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine and Department of Transplantation Medicine, New York Presbyterian-Weill Cornell Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ikle","sequence":"additional","affiliation":[{"name":"Rho Federal Systems, Chapel Hill, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Demetris","sequence":"additional","affiliation":[{"name":"Division of Transplantation Pathology, Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tuschl","sequence":"additional","affiliation":[{"name":"Laboratory of RNA Molecular Biology, The Rockefeller University, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikkam","family":"Suthanthiran","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine and Department of Transplantation Medicine, New York Presbyterian-Weill Cornell Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"issue":"suppl s1","key":"R1-20250607","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ajt.15674","article-title":"OPTN\/SRTR 2018 annual data report: liver.","volume":"20","author":"Kwong","year":"2020","journal-title":"Am J Transplant"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1016\/j.jhep.2015.02.042","article-title":"From immunosuppression to tolerance.","volume":"62","author":"Adams","year":"2015","journal-title":"J Hepatol"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.trre.2018.04.001","article-title":"Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression.","volume":"32","author":"Cillo","year":"2018","journal-title":"Transplant Rev (Orlando)"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/lt.22265","article-title":"Operational tolerance: past lessons and future prospects.","volume":"17","author":"Levitsky","year":"2011","journal-title":"Liver Transpl"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 comprehensive update of the Banff Working Group on liver allograft pathology: introduction of antibody-mediated rejection.","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.1840140619","article-title":"Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy.","volume":"14","author":"Bubak","year":"1991","journal-title":"Hepatology"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy.","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/00007890-199305000-00029","article-title":"Liver biopsy. Its safety and complications as seen at a liver transplant center.","volume":"55","author":"Van Thiel","year":"1993","journal-title":"Transplantation"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/ajt.15205","article-title":"Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.","volume":"19","author":"Shaked","year":"2019","journal-title":"Am J Transplant"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function.","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MOT.0000000000000148","article-title":"MicroRNAs as master regulators of immune responses in transplant recipients.","volume":"20","author":"Kaul","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri.2016.40","article-title":"MicroRNAs as regulatory elements in immune system logic.","volume":"16","author":"Mehta","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"11151","DOI":"10.1073\/pnas.1401724111","article-title":"Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers.","volume":"111","author":"Akat","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1073\/pnas.0813121106","article-title":"MicroRNA expression profiles predictive of human renal allograft status.","volume":"106","author":"Anglicheau","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cell.2019.03.023","article-title":"The extracellular RNA communication consortium: establishing foundational knowledge and technologies for extracellular RNA research.","volume":"177","author":"Das","year":"2019","journal-title":"Cell"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cll.2018.10.003","article-title":"MicroRNAs and transplantation.","volume":"39","author":"Khan","year":"2019","journal-title":"Clin Lab Med"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection.","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/hep.28786","article-title":"An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.","volume":"65","author":"Shaked","year":"2017","journal-title":"Hepatology"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1073\/pnas.1412608111","article-title":"Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis.","volume":"111","author":"Ward","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1261\/rna.1947110","article-title":"Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression.","volume":"16","author":"Git","year":"2010","journal-title":"RNA"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"e000792","DOI":"10.1161\/JAHA.113.000792","article-title":"Circulating microRNAs: understanding the limits for quantitative measurement by real-time PCR.","volume":"3","author":"Hardikar","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nmeth.3014","article-title":"Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study.","volume":"11","author":"Mestdagh","year":"2014","journal-title":"Nat Methods"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2144\/000114002","article-title":"A comparison of miRNA isolation and RT-qPCR technologies and their effects on quantification accuracy and repeatability.","volume":"54","author":"Redshaw","year":"2013","journal-title":"Biotechniques"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/lt.23481","article-title":"Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance.","volume":"18","year":"2012","journal-title":"Liver Transpl"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ymeth.2012.07.030","article-title":"Barcoded cDNA library preparation for small RNA profiling by next-generation sequencing.","volume":"58","author":"Hafner","year":"2012","journal-title":"Methods"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1158\/0008-5472.CAN-11-0608","article-title":"MicroRNA sequence and expression analysis in breast tumors by deep sequencing.","volume":"71","author":"Farazi","year":"2011","journal-title":"Cancer Res"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1471-2105-11-367","article-title":"A flexible R package for nonnegative matrix factorization.","volume":"11","author":"Gaujoux","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1471-2164-14-298","article-title":"5 tRNA halves are present as abundant complexes in serum, concentrated in blood cells, and modulated by aging and calorie restriction.","volume":"14","author":"Dhahbi","year":"2013","journal-title":"BMC Genomics"},{"key":"R31-20250607","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A mammalian microRNA expression atlas based on small RNA library sequencing.","volume":"129","author":"Landgraf","year":"2007","journal-title":"Cell"},{"key":"R32-20250607","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510310316","article-title":"Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis.","volume":"31","author":"Tai","year":"2000","journal-title":"Hepatology"},{"key":"R33-20250607","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2199-13-4","article-title":"Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells.","volume":"13","author":"Li","year":"2012","journal-title":"BMC Mol Biol"},{"key":"R34-20250607","doi-asserted-by":"crossref","first-page":"e23937","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.","volume":"6","author":"Cermelli","year":"2011","journal-title":"PLoS One"},{"key":"R35-20250607","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/lt.22438","article-title":"Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation.","volume":"18","author":"Farid","year":"2012","journal-title":"Liver Transpl"},{"key":"R36-20250607","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/lt.25842","article-title":"MicroRNAs 155-5p, 122-5p, and 181a-5p identify patients with graft dysfunction due to T cell-mediated rejection after liver transplantation.","volume":"26","author":"Ruiz","year":"2020","journal-title":"Liver Transpl"},{"key":"R37-20250607","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1042\/BST0361220","article-title":"Regulation of hepatitis C virus by microRNA-122.","volume":"36","author":"Jopling","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"R38-20250607","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pbi.2015.07.008","article-title":"Mechanisms of microRNA turnover.","volume":"27","author":"Sanei","year":"2015","journal-title":"Curr Opin Plant Biol"},{"key":"R39-20250607","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/toxsci\/kfu232","article-title":"Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.","volume":"143","author":"Krauskopf","year":"2015","journal-title":"Toxicol Sci"},{"key":"R40-20250607","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/jvh.12138","article-title":"Studying the association of microRNA-210 level with chronic hepatitis B progression.","volume":"21","author":"Song","year":"2014","journal-title":"J Viral Hepat"},{"key":"R41-20250607","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/lt.23613","article-title":"Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation.","volume":"19","author":"Joshi","year":"2013","journal-title":"Liver Transpl"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T16:10:17Z","timestamp":1749312617000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003815","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,11]]}}}